WO2006018703A3 - Procedes de preparation de la narwedine et son utilisation dans la synthese de galantamine - Google Patents

Procedes de preparation de la narwedine et son utilisation dans la synthese de galantamine Download PDF

Info

Publication number
WO2006018703A3
WO2006018703A3 PCT/IB2005/002431 IB2005002431W WO2006018703A3 WO 2006018703 A3 WO2006018703 A3 WO 2006018703A3 IB 2005002431 W IB2005002431 W IB 2005002431W WO 2006018703 A3 WO2006018703 A3 WO 2006018703A3
Authority
WO
WIPO (PCT)
Prior art keywords
narwedine
synthesis
galantamine
processes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/002431
Other languages
English (en)
Other versions
WO2006018703A2 (fr
Inventor
Saswata Lahiri
Mohan Prasad
Nitin Maheshwari
Yatendra Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006018703A2 publication Critical patent/WO2006018703A2/fr
Publication of WO2006018703A3 publication Critical patent/WO2006018703A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des procédés de préparation de la narwedine et son utilisation dans la synthèse de galantamine pure et de ses sels. La présente invention concerne également un nouveau sel d'addition acide de narwedine isopropylène glycol cétal (de la formule I) qui est un intermédiaire utile dans la synthèse de la narwedine et de la galantamine.
PCT/IB2005/002431 2004-08-16 2005-08-15 Procedes de preparation de la narwedine et son utilisation dans la synthese de galantamine Ceased WO2006018703A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN1504/DEL/2004 2004-08-16
IN1504DE2004 2004-08-16
IN1505DE2004 2004-08-16
IN1505/DEL/2004 2004-08-16
IN1551DE2004 2004-08-19
IN1551/DEL/2004 2004-08-19

Publications (2)

Publication Number Publication Date
WO2006018703A2 WO2006018703A2 (fr) 2006-02-23
WO2006018703A3 true WO2006018703A3 (fr) 2006-07-20

Family

ID=35788180

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/IB2005/002431 Ceased WO2006018703A2 (fr) 2004-08-16 2005-08-15 Procedes de preparation de la narwedine et son utilisation dans la synthese de galantamine
PCT/IB2005/002429 Ceased WO2006046096A2 (fr) 2004-08-16 2005-08-15 Forme polymorphe de la narwedine et son utilisation dans la synthese de la galantamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/002429 Ceased WO2006046096A2 (fr) 2004-08-16 2005-08-15 Forme polymorphe de la narwedine et son utilisation dans la synthese de la galantamine

Country Status (1)

Country Link
WO (2) WO2006018703A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012692A1 (fr) * 1994-10-21 1996-05-02 Waldheim Pharmazeutika Gesellschaft M.B.H. PROCEDE DE PREPARATION DE DERIVES DE 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE
WO1998052885A1 (fr) * 1997-05-21 1998-11-26 Sanochemia Pharmazeutika Aktiengesellschaft Reduction d'halogenures aromatiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610887D0 (en) * 1996-05-24 1996-07-31 N H S Trust Process
GB9707413D0 (en) * 1997-04-11 1997-05-28 Chiroscience Ltd Process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012692A1 (fr) * 1994-10-21 1996-05-02 Waldheim Pharmazeutika Gesellschaft M.B.H. PROCEDE DE PREPARATION DE DERIVES DE 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE
WO1998052885A1 (fr) * 1997-05-21 1998-11-26 Sanochemia Pharmazeutika Aktiengesellschaft Reduction d'halogenures aromatiques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARTON D H R ET AL: "PHENOL OXIDATION AND BIOSYNTHESIS. PART V. THE SYNTHESIS OF GALANTHAMINE", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL SOCIETY. LETCHWORTH, GB, 1962, pages 806 - 817, XP009062110, ISSN: 0368-1769 *
CHAPLIN D A ET AL: "A Concise, Scaleable Synthesis of Narwedine", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 38, no. 45, 10 November 1997 (1997-11-10), pages 7931 - 7932, XP004097210, ISSN: 0040-4039 *
NODE M ET AL: "AN EFFICIENT SYNTHESIS OF (PLUS OR MINUS)-NARWEDINE AND (PLUS OR MINUS)-GALANTHAMINE BY AN IMPROVED PHENOLIC OXIDATIVE COUPLING", ANGEWANDTE CHEMIE. INTERNATIONAL EDITION, WILEY VCH VERLAG, WEINHEIM, DE, vol. 40, no. 16, 2001, pages 3060 - 3062, XP008043770, ISSN: 1433-7851 *

Also Published As

Publication number Publication date
WO2006018703A2 (fr) 2006-02-23
WO2006046096A2 (fr) 2006-05-04
WO2006046096A3 (fr) 2006-08-24

Similar Documents

Publication Publication Date Title
WO2006072393A3 (fr) Sulfonylpyrrolidines, procede pour les produire et leur utilisation comme medicaments
WO2006027705A3 (fr) Synthese de triethylenetetramines
WO2006048330A8 (fr) Inhibiteurs de la 11????-hsd1
EP1604989A8 (fr) Inhibiteurs de DPP-IV
WO2006021454A3 (fr) Derives de pyrimidine
WO2012042534A3 (fr) Procédés de préparation de r-sitagliptine et de ses intermédiaires
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
WO2009047499A3 (fr) Procédés de préparation de palipéridone et de ses sels pharmaceutiquement acceptables et d'intermédiaires pour une utilisation dans les procédés
EP1598341A8 (fr) Inhibiteurs de DPP-IV
CA2561590A1 (fr) Nouveau procede de preparation d'intermediaires utilises dans la synthese d'analogues de vitamine d
WO2006042954A8 (fr) Dérivés de 2-amido-4-phenylthiazole, leur préparation et leur application en thérapeutique
EP1604980A8 (fr) Inhibiteurs de DPP-IV
WO2005033066A3 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique sanofi-synthelabo
WO2006047415A3 (fr) Composes inhibiteurs du facteurs xa
WO2005121078A3 (fr) Composes cyclopentene substitues
WO2004111008A3 (fr) Utilisation d'un compose de formule i pour la preparation d'une composition pharmaceutique
ECSP067111A (es) Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica
IL183271A0 (en) Crystalline form of cefdinir ammonium salt as an intermediate for the preparation of pure cefdinir
WO2005123049A3 (fr) Composition pharmaceutique permettant d'augmenter la genese mitochondrienne
WO2006018703A3 (fr) Procedes de preparation de la narwedine et son utilisation dans la synthese de galantamine
WO2006066044A3 (fr) Procedes de production de 4-aminoquinazolines
WO2009021943A3 (fr) Nouveau procédé de préparation
WO2005033279A3 (fr) Decouverte de nouveaux anesthesiques solubles cristallins
WO2007010356A3 (fr) Procede pour la preparation de derives de sulfonamide
TW200502235A (en) Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase